Detalhe da pesquisa
1.
Quantitative subcellular acyl-CoA analysis reveals distinct nuclear metabolism and isoleucine-dependent histone propionylation.
Mol Cell
; 82(2): 447-462.e6, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34856123
2.
Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate.
Nature
; 579(7800): 586-591, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32214246
3.
PRKCI promotes immune suppression in ovarian cancer.
Genes Dev
; 31(11): 1109-1121, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28698296
4.
An Integrated Hepatocyte Stability Assay for Simultaneous Metabolic Stability Assessment and Metabolite Profiling.
Drug Metab Dispos
; 52(5): 377-389, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438166
5.
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib.
Gynecol Oncol
; 187: 105-112, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38759516
6.
Efficacy of ChatGPT in Cantonese Sentiment Analysis: Comparative Study.
J Med Internet Res
; 26: e51069, 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289662
7.
Tracking and Profiling Repeated Users Over Time in Text-Based Counseling: Longitudinal Observational Study With Hierarchical Clustering.
J Med Internet Res
; 26: e50976, 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38815258
8.
Bioactivation and reactivity research advances - 2022 year in review.
Drug Metab Rev
; 55(4): 267-300, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608698
9.
Biotransformation research advances - 2022 year in review.
Drug Metab Rev
; 55(4): 301-342, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37737116
10.
Pilot randomized trial of an acceptance-based telehealth intervention for women with ovarian cancer and PARP inhibitor-related fatigue.
Gynecol Oncol
; 177: 165-172, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37708581
11.
Oral enzyme therapy for maple syrup urine disease (MSUD) suppresses plasma leucine levels in intermediate MSUD mice and healthy nonhuman primates.
J Inherit Metab Dis
; 46(6): 1089-1103, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494004
12.
Rational Combinations of PARP Inhibitors with HRD-Inducing Molecularly Targeted Agents.
Cancer Treat Res
; 186: 171-188, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37978136
13.
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours.
Br J Cancer
; 126(7): 1027-1036, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34887522
14.
Norepinephrine and dopamine contribute to distinct repetitive behaviors induced by novel odorant stress in male and female mice.
Horm Behav
; 144: 105205, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35660247
15.
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.
J Natl Compr Canc Netw
; 20(9): 972-980, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075393
16.
ADAGIO: a phase IIb international study of the Wee1 inhibitor adavosertib in women with recurrent or persistent uterine serous carcinoma.
Int J Gynecol Cancer
; 32(1): 89-92, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716177
17.
A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors.
Int J Clin Oncol
; 27(12): 1881-1890, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344654
18.
Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial.
Lancet Oncol
; 22(5): 632-642, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33862001
19.
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
N Engl J Med
; 379(26): 2495-2505, 2018 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30345884
20.
Uterine serous carcinoma: Molecular features, clinical management, and new and future therapies.
Gynecol Oncol
; 160(1): 322-332, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33160694